Ísrael - enska - Ministry of Health

padagis israel agencies ltd, israel - acetylsalicylic acid; caffeine; paracetamol - caplets - acetylsalicylic acid 250 mg; paracetamol 250 mg; caffeine 65 mg - acetylsalicylic acid - acetylsalicylic acid - for temporary relief of the pain of headache, mild to moderate pain associated with migraine headache, pain of menstrual descomfort and pain accompanied by fever.

Ísrael - enska - Ministry of Health

padagis israel agencies ltd, israel - acetylsalicylic acid; caffeine; paracetamol - caplets - acetylsalicylic acid 250 mg; caffeine 65 mg; paracetamol 250 mg - acetylsalicylic acid, combinations with psycholeptics - acetylsalicylic acid, combinations with psycholeptics - for temporary relief of the pain of headache mild to moderate pain associated with migraine, pain of menstrual discomfort and pain accompanied by fever.

Bandaríkin - enska - NLM (National Library of Medicine)

elorac, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 285 mg in 1 ml

Bandaríkin - enska - NLM (National Library of Medicine)

smg pharmaceuticals, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 30 mg in 1 g - an external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. these conditions include complications associated with pyodermas. indicated also in the treatment of insect bites, burns and fungal infections. bensal hp® is contraindicated for use in those patients who are hypersensitive to topical polyethylene glycols. safety and effectiveness in pediatric patients has not been established.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - fluorouracil, quantity: 0.5 g; salicylic acid, quantity: 10 g - solution - excipient ingredients: butyl methacrylate/methyl methacrylate copolymer (3:1); ethyl acetate; dimethyl sulfoxide; ethanol absolute; pyroxylin - actikerall is indicated for the topical treatment of solar (actinic) keratosis

Malasía - enska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

xorix sdn bhd - salicylic acid -

Bandaríkin - enska - NLM (National Library of Medicine)

acella pharmaceuticals, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 275 mg in 1 ml - salicylic acid, 27.5% wart remover is indicated for the topical treatment and removal of common warts and plantar warts. salicylic acid, 27.5% wart remover should not be used by diabetics or patients with impaired blood circulation. salicylic acid, 27.5% wart remover should not be used on moles, birthmarks, unusual warts with hair growing from them or warts on the face.

Bandaríkin - enska - NLM (National Library of Medicine)

rochester pharmaceuticals - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 260 mg in 1 ml - salicylic acid, 26% is indicated for the topical treatment and removal of common warts and plantar warts. salicylic acid, 26% should not be used by diabetics or patients with impaired blood circulation. salicylic acid, 26% should not be used on moles, birthmarks, unusual warts with hair growing from them or warts on the face.

Bandaríkin - enska - NLM (National Library of Medicine)

prugen, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 27.24 g in 1 g - salicylic acid 6% (w/w) cream is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic acid 6% (w/w) cream is a topical aid in the removal of excessive keratin on the dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% (w/w) cream should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% (w/w) cream should not be used in children under 2 years of age.

Bandaríkin - enska - NLM (National Library of Medicine)

prugen llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 mg in 100 ml - salicylic acid 6% (w/w) shampoo is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). salicylic acid 6% (w/w) shampoo is a topical aid in the removal of excessive keratin on the dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% (w/w) shampoo should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% (w/w) shampoo should not be used in children under 2 years of age.